Home › Austin biotech firm seeks $15M on Wall Street to continue fight against cancer
 

Keywords :   


Austin biotech firm seeks $15M on Wall Street to continue fight against cancer

2015-07-14 22:18:24| Biotech - Topix.net

The Austin-based health diagnostics company focused on tests for ovarian cancer has priced a common stock offering of 8.35 million shares at $1.96 per share, the company said Tuesday. Net proceeds are expected to be about $15.2 million.

Tags: street continue firm wall

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
21.09Atlantic Tropical Weather Outlook
21.09Eastern North Pacific Tropical Weather Outlook
20.09Labelexpo Americas highlights, Maxcess announces acquisition and more
20.09September Cattle on Feed as expected
20.09USDA announces major investment in meat and poultry processing
20.09Atlantic Tropical Weather Outlook
20.09Eastern North Pacific Tropical Weather Outlook
20.09This weeks lesson: Weaning matters in the cattle market
More »